Langerhans cell histiocytosis of vulva in adolescent

International Journal of Gynecological Cancer

Volumn 17, Issue 2, 2007, Pages 520-524

  Mottl, H ^a   Rob, L ^a   Stary, J ^a   Kodet, R ^a   Drahokoupilova, E ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adolescent; Langerhans cell histiocytosis; Treatment; Vulva

Indexed keywords

ACICLOVIR; CLADRIBINE; CORTICOSTEROID; PREDNISONE; PROTEIN S 100; T6 ANTIGEN; VINBLASTINE;

ADOLESCENT; ARTICLE; BIOPSY; BONE MARROW BIOPSY; BONE MARROW TOXICITY; BONE SCINTISCANNING; CASE REPORT; CHEMOTHERAPY; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EOSINOPHIL; FEMALE; GYNECOLOGY; HISTIOCYTE; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; REMISSION; SKIN DEFECT; THORAX RADIOGRAPHY; VESICULAR RASH; VULVITIS;

ADOLESCENT; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; VULVAR DISEASES;

EID: 33947239339     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00791.x     Document Type: Article

References (30)

1. Lichtenstein L. Histiocytosis X: integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schiller-Christian disease as related manifestations of a single nosology entity. Arch Pathol 1953;56:84-102.
2. Ladish S, Jaffe ES. The histiocytoses. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology, 4th edn. Philadelphia, PA: Lippincott, 2002:733-50.
3. Mottl H, Mracek J, Kabelka Z, Tichy M, Schütz P, Kodet R. Histiocytosis from Langerhans cells in children. Cs Pediatr 1992;47:530-3.
4. Maltas JS. Langerhans cell histiocytosis in adults. Hematom Oncol Clin North Am 1998;12:259-68.
5. Broadbent V, Gadner H. Current therapy for Langerhans cell histocytosis. Hematol Oncol Clin North Am 1998;12:327-8.
6. Mottl H, Ganevova M, Radvanska J et al. Outcome of treatment of Langerhans cell histiocytosis according to the LCH II protocol. Cas Lek Cesk 2005;144:753-5.
7. Axiotis CA, Merino MJ, Duray PH. Langerhans cell histiocytosis of the female genital tract. Cancer 1991;67:1650-60.
8. Jaffe R. The diagnostic histopathology of Langerhans cell histiocytosis. In: Weitzman S, Egeler RM, eds. Histiocytic disorders of children and adults, 1st edn. Cambridge: Cambridge University Press, 2002:14-38.
9. Lane CW, Smith MG. Cutaneous manifestations of chronic (idiopathic) lipoidosis (Hand-Schüller-Christian disease): report of four cases, including autopsy observations. Arch Derm Syph 1939;39:617-44.
10. Rose PG, Johnston GC, O'Toole RV. Pure cutaneous histiocytosis of the vulva. Obstet Gynecol 1984;64:587-90.
11. Gnassia AM, Gnassia T, Bonvalet D, Puissant A, Goudal H. Histiocytose X' granuloma eosinophile vulvaire. Effect spectaculaire de la thalidomide. Ann Dermatos Venerik 1987;114:1387-9.
12. Voelklein K, Horny HP, Marzusch K, Dietl J. Primary Langerhans cell histiocytosis of the vulva. Gynecol Obstet Incest 1993;36:189-90.
13. Savell V, Hanna R, Benda JA, Argenyi ZB. Histiocytosis X of the vulva with a confusing clinical and pathologic presentation. A case report. J Repris Med 1995;40:323-6.
14. Solano T, Espana A, Sola J, Lopez G. Langerhans' cell histiocytosis on the vulva. Gynecol Oncol 2000;78:251-4.
15. Pather S, Moodley JM, Bramdev A. Isolated Langerhans cell histiocytosis of the vulva: a case report. J Obstet Gynaecol Res 2001;27:111-5.
16. Santillan A, Montero AJ, Kavanagh JJ, Liu J, Ramirez P. Vulvar Langerhans cell histiocytosis: a case report and review of the literature. Gynecol Oncol 2003;91:241-6.
17. Padula A, Medeiros LJ, Silva EG, Deavers MT. Isolated vulvar Langerhans cell histiocytosis: report of two cases. Int J Gynecol Pathol 2004;23:278-83.
18. Ishigaki H, Hatta N, Yamada M, Orito H, Takehara K. Localised vulva Langerhans cell histiocytosis. Eur J Dermatol 2004;14:412-14.
19. Venizelos ID, Mandala E, Tatsiou ZA, Acholos V, Goutzioulis M. Primary langerhans cell histiocytosis of the vulva. Int J Gynecol Pathol 2006;25:48-51.
20. Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematom Oncol Clin North Am 1998;12:269-86.
21. Chu T. Langerhans cell histiocytosis. Australian J Dermatos 2001;42:237-42.
22. Dallafior S, Pugin P, Cerny T, Betticher D, Saurat JH, Hauser C. Successful treatment of a case of cutaneous Langerhans cell granulomatosis with 2-chlorodeoxyadenosine and thalidomide. Hautarzt 1995;46:553-60.
23. Tseng S, Pak G, Washenik K, Pomeranz MK, Shupack JL. Rediscovering thalidomide. A review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatos 1996;35:969-79.
24. Lima LM, Astro P, Machalo AL. Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues. Bioorg Med Chem 2002;10:3067-73.
25. Thomas L, Ducros B, Secchi T, Balme B, Moulin G. Successful treatment of adult's langerhans cell histiocytosis with thalidomide. Report of two cases and literature review. Arch Dermatol 1993;129:1261-4.
26. Ladish S, Gauner H. Treatment of Langerhans cell histiocytosis - evolution and current approach. Br J Cancer 1994;23(Suppl.):S41-6.
27. Pardanani A, Phyliky RL, ChY Li, Tefferi A. 2-Chlorodeoxyadenosine therapy for disseminated langerhans cell histiocytosis. Mayo Clin Proc 2003;78:301-6.
28. Goh NSL, ChF Macdonald, MacGregor DP, Presto JJ, Brodie GN. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Respirology 2003;8:91-4.
29. Stine KC, Saylors RL, Saccente S, McClain KL, Beton DL. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with langerhans cell histiocytosis. Ped Blood Canc 2004;43:81-4.
30. Mottl H, Stary J, Chanova M, Nekolna M, Drahokoupilova E, Smelhaus V. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine. Leuk Lymphoma 2006 (in press).